Old Web
English
Sign In
Acemap
>
authorDetail
>
James T. VanderLugt
James T. VanderLugt
Medicine
Internal medicine
Atrial fibrillation
Spinal muscular atrophy
CD14
4
Papers
64
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics and Bioequivalence of Branded and Generic Formulations of Dofetilide 0.5‐mg Capsules After Single‐Dose Administration in Healthy Subjects
2018
Clinical pharmacology in drug development
James T. VanderLugt
Charles Bon
Dean Knuth
Rhonda Schreiber
Michael D. Ruff
Show All
Source
Cite
Save
Citations (1)
An Evaluation of MSDC-0160, A Prototype mTOT Modulating Insulin Sensitizer, in Patients with Mild Alzheimer’s Disease
2014
Current Alzheimer Research
Raj C. Shah
Dawn C. Matthews
Randolph D. Andrews
Ana W. Capuano
Debra A. Fleischman
James T. VanderLugt
Jerry R Colca
Show All
Source
Cite
Save
Citations (29)
The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm.
1997
The American Journal of Managed Care
Gary A. Zarkin
Mohan V. Bala
Ma Brian Calingaert
James T. VanderLugt
Show All
Source
Cite
Save
Citations (20)
1